Your browser doesn't support javascript.
loading
Adaptive Admixture of HLA Class I Allotypes Enhanced Genetically Determined Strength of Natural Killer Cells in East Asians.
Deng, Zhihui; Zhen, Jianxin; Harrison, Genelle F; Zhang, Guobin; Chen, Rui; Sun, Ge; Yu, Qiong; Nemat-Gorgani, Neda; Guethlein, Lisbeth A; He, Liumei; Tang, Mingzhong; Gao, Xiaojiang; Cai, Siqi; Palmer, William H; Shortt, Jonathan A; Gignoux, Christopher R; Carrington, Mary; Zou, Hongyan; Parham, Peter; Hong, Wenxu; Norman, Paul J.
Afiliação
  • Deng Z; Immunogenetics Laboratory, Shenzhen Blood Center, Shenzhen, Guangdong, P. R. China.
  • Zhen J; Department of Transfusion Medicine, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, Guangdong, P. R. China.
  • Harrison GF; Immunogenetics Laboratory, Shenzhen Blood Center, Shenzhen, Guangdong, P. R. China.
  • Zhang G; Central Laboratory, Shenzhen Baoan Women's and Children's Hospital, Shenzhen, Guangdong, P. R. China.
  • Chen R; Division of Biomedical Informatics and Personalized Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
  • Sun G; Immunogenetics Laboratory, Shenzhen Blood Center, Shenzhen, Guangdong, P. R. China.
  • Yu Q; Immunogenetics Laboratory, Shenzhen Blood Center, Shenzhen, Guangdong, P. R. China.
  • Nemat-Gorgani N; Immunogenetics Laboratory, Shenzhen Blood Center, Shenzhen, Guangdong, P. R. China.
  • Guethlein LA; Immunogenetics Laboratory, Shenzhen Blood Center, Shenzhen, Guangdong, P. R. China.
  • He L; Department of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA.
  • Tang M; Department of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA.
  • Gao X; Immunogenetics Laboratory, Shenzhen Blood Center, Shenzhen, Guangdong, P. R. China.
  • Cai S; Clinical Laboratory, Wuzhou Red Cross Hospital, Wuzhou, Guangxi, P. R. China.
  • Palmer WH; Inflammatory Cell Dynamics Section, Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Shortt JA; Immunogenetics Laboratory, Shenzhen Blood Center, Shenzhen, Guangdong, P. R. China.
  • Gignoux CR; Division of Biomedical Informatics and Personalized Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
  • Carrington M; Division of Biomedical Informatics and Personalized Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
  • Zou H; Division of Biomedical Informatics and Personalized Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
  • Parham P; Basic Science Program, Frederick National Laboratory for Cancer Research (FNLCR), Frederick, MD21702, and Ragon Institute of MGH, Cambridge, MA, USA.
  • Hong W; Immunogenetics Laboratory, Shenzhen Blood Center, Shenzhen, Guangdong, P. R. China.
  • Norman PJ; Department of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA.
Mol Biol Evol ; 38(6): 2582-2596, 2021 05 19.
Article em En | MEDLINE | ID: mdl-33616658
ABSTRACT
Human natural killer (NK) cells are essential for controlling infection, cancer, and fetal development. NK cell functions are modulated by interactions between polymorphic inhibitory killer cell immunoglobulin-like receptors (KIR) and polymorphic HLA-A, -B, and -C ligands expressed on tissue cells. All HLA-C alleles encode a KIR ligand and contribute to reproduction and immunity. In contrast, only some HLA-A and -B alleles encode KIR ligands and they focus on immunity. By high-resolution analysis of KIR and HLA-A, -B, and -C genes, we show that the Chinese Southern Han (CHS) are significantly enriched for interactions between inhibitory KIR and HLA-A and -B. This enrichment has had substantial input through population admixture with neighboring populations, who contributed HLA class I haplotypes expressing the KIR ligands B*4601 and B*5801, which subsequently rose to high frequency by natural selection. Consequently, over 80% of Southern Han HLA haplotypes encode more than one KIR ligand. Complementing the high number of KIR ligands, the CHS KIR locus combines a high frequency of genes expressing potent inhibitory KIR, with a low frequency of those expressing activating KIR. The Southern Han centromeric KIR region encodes strong, conserved, inhibitory HLA-C-specific receptors, and the telomeric region provides a high number and diversity of inhibitory HLA-A and -B-specific receptors. In all these characteristics, the CHS represent other East Asians, whose NK cell repertoires are thus enhanced in quantity, diversity, and effector strength, likely augmenting resistance to endemic viral infections.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Genes MHC Classe I / Células Matadoras Naturais / Evolução Molecular / Receptores KIR Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Mol Biol Evol Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Genes MHC Classe I / Células Matadoras Naturais / Evolução Molecular / Receptores KIR Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Mol Biol Evol Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2021 Tipo de documento: Article